Spots Global Cancer Trial Database for protein expression analysis
Every month we try and update this database with for protein expression analysis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma | NCT00482495 | Multiple Myelom... | bevacizumab gene expression... protein express... laboratory biom... | 18 Years - | Mayo Clinic | |
| Study of Hair Samples From Patients With Cancer | NCT00899691 | Unspecified Adu... | protein express... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Biomarkers in Samples From Young Patients With Neuroblastoma | NCT01358604 | Neuroblastoma | polymerase chai... protein express... western blottin... flow cytometry immunohistochem... laboratory biom... | - 120 Years | Children's Oncology Group | |
| Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Cancer | NCT00546377 | Leukemia Lymphoma | filgrastim pegfilgrastim rituximab sargramostim cyclophosphamid... mitoxantrone hy... pentostatin fluorescence in... gene rearrangem... polymerase chai... protein express... flow cytometry biopsy | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment | NCT00673569 | Lung Cancer | erlotinib hydro... gene expression... protein express... immunoenzyme te... immunologic tec... laboratory biom... needle biopsy | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors | NCT00372736 | Unspecified Adu... | AEG35156 docetaxel protein express... reverse transcr... flow cytometry immunoenzyme te... immunohistochem... laboratory biom... | 18 Years - | Canadian Cancer Trials Group | |
| Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00589056 | Lung Cancer | cisplatin etoposide nelfinavir mesy... protein express... immunohistochem... laboratory biom... biopsy radiation thera... | 18 Years - 120 Years | Abramson Cancer Center at Penn Medicine | |
| Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer | NCT00899132 | Non-melanomatou... Pancreatic Canc... Small Intestine... Testicular Germ... | in situ hybridi... protein express... immunologic tec... | - | Case Comprehensive Cancer Center | |
| Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | NCT00667901 | Melanoma (Skin) | riluzole protein express... reverse transcr... western blottin... immunohistochem... laboratory biom... pharmacological... neoadjuvant the... therapeutic con... | 18 Years - | Rutgers, The State University of New Jersey | |
| Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma | NCT01103375 | Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Recurrent Adult... | erlotinib hydro... isotretinoin laboratory biom... protein express... | 18 Years - | Wake Forest University Health Sciences | |
| Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx | NCT00899340 | Head and Neck C... | gene expression... microarray anal... protein express... immunohistochem... laboratory biom... | - | Vanderbilt-Ingram Cancer Center | |
| Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | NCT00667901 | Melanoma (Skin) | riluzole protein express... reverse transcr... western blottin... immunohistochem... laboratory biom... pharmacological... neoadjuvant the... therapeutic con... | 18 Years - | Rutgers, The State University of New Jersey | |
| Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy | NCT00897299 | Breast Cancer Estrogen Recept... Her-2 Pgr | microarray anal... protein express... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | NCT00492440 | Kidney Cancer Melanoma (Skin) | recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological... | 18 Years - | Cytheris SA | |
| Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy | NCT01194635 | Head and Neck C... | fluorescence in... gene expression... polymerase chai... protein analysi... protein express... enzyme-linked i... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors | NCT01544569 | Kidney Cancer | DNA analysis fluorescence in... gene expression... gene mapping microarray anal... polymerase chai... protein express... laboratory biom... medical chart r... | - 1 Year | Children's Oncology Group | |
| Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | NCT00176527 | Prostate Cancer | recombinant int... docetaxel estramustine ph... isotretinoin polyacrylamide ... protein express... immunohistochem... | 18 Years - | Rutgers, The State University of New Jersey | |
| Tumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524 | NCT00898820 | Lung Cancer | gene expression... polymorphism an... protein express... | 18 Years - | Mayo Clinic | |
| Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | NCT00524589 | Prostate Cancer | calcitriol dexamethasone protein express... laboratory biom... | - 120 Years | Roswell Park Cancer Institute | |
| Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma | NCT01366157 | Lymphoma | microarray anal... protein express... immunohistochem... laboratory biom... | - 21 Years | Children's Oncology Group | |
| Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma | NCT01387724 | Neuroblastoma | RNA analysis polymerase chai... protein express... proteomic profi... western blottin... enzyme-linked i... immunohistochem... laboratory biom... liquid chromato... mass spectromet... | 1 Year - 10 Years | Children's Oncology Group | |
| Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma | NCT01390571 | Brain and Centr... | olaparib temozolomide gene expression... protein express... laboratory biom... pharmacological... diffusion-weigh... dynamic contras... therapeutic con... | 18 Years - | Cancer Research UK | |
| DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE | NCT00900536 | Kidney Cancer | mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx | NCT00899340 | Head and Neck C... | gene expression... microarray anal... protein express... immunohistochem... laboratory biom... | - | Vanderbilt-Ingram Cancer Center | |
| Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00390403 | Brain and Centr... | R-(-)-gossypol ... temozolomide gene expression... mutation analys... protein express... laboratory biom... pharmacological... adjuvant therap... radiation thera... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | NCT00492440 | Kidney Cancer Melanoma (Skin) | recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological... | 18 Years - | Cytheris SA | |
| Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer | NCT00499655 | Recurrent Non-s... Stage IIIB Non-... Stage IV Non-sm... | erlotinib hydro... celecoxib placebo laboratory biom... immunohistochem... fluorescence in... mutation analys... protein express... gene expression... | 18 Years - | City of Hope Medical Center | |
| Studying Gene Expression in Samples From Younger Patients With Neuroblastoma | NCT01553448 | Neoplastic Synd... Neuroblastoma | gene expression... protein express... enzyme-linked i... immunohistochem... laboratory biom... medical chart r... | - 21 Years | Children's Oncology Group | |
| Genetics of Women With Lobular Carcinoma in Situ of the Breast | NCT00536718 | Breast Cancer | gene expression... molecular diagn... polymorphism an... protein express... medical chart r... questionnaire a... | - 60 Years | National Cancer Institute (NCI) | |
| Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803 | NCT00897351 | Prostate Cancer | mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer | NCT00343512 | Breast Cancer | docetaxel protein express... laboratory biom... biopsy conventional su... neoadjuvant the... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Study of Proteins in Head and Neck Cancer Cells | NCT00896948 | Head and Neck C... | Southern blotti... TdT-mediated dU... gene expression... protein express... flow cytometry fluorescent ant... immunoenzyme te... immunohistochem... immunologic tec... | - 120 Years | Vanderbilt University Medical Center | |
| Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery | NCT00665457 | Breast Cancer | filgrastim capecitabine celecoxib cyclophosphamid... docetaxel doxorubicin hyd... gene expression... polymorphism an... protein express... reverse transcr... imaging biomark... immunohistochem... laboratory biom... pharmacogenomic... dynamic contras... needle biopsy neoadjuvant the... radiomammograph... ultrasound imag... | 19 Years - 120 Years | University of Nebraska | |
| DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE | NCT00900536 | Kidney Cancer | mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Panobinostat and Epirubicin in Treating Patients With Metastatic Malignant Solid Tumors | NCT00878904 | Unspecified Adu... | epirubicin hydr... panobinostat gene expression... protein express... western blottin... immunologic tec... laboratory biom... pharmacological... | 18 Years - 120 Years | University of California, San Francisco | |
| Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer | NCT00499655 | Recurrent Non-s... Stage IIIB Non-... Stage IV Non-sm... | erlotinib hydro... celecoxib placebo laboratory biom... immunohistochem... fluorescence in... mutation analys... protein express... gene expression... | 18 Years - | City of Hope Medical Center | |
| Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite | NCT00897247 | Malignant Mesot... Pulmonary Compl... | microarray anal... protein express... proteomic profi... laboratory biom... | 25 Years - 80 Years | Barbara Ann Karmanos Cancer Institute | |
| Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer | NCT00896857 | Breast Cancer | RNA analysis polymerase chai... protein express... reverse transcr... western blottin... immunoenzyme te... immunohistochem... laboratory biom... breast duct lav... | - 120 Years | Wake Forest University Health Sciences | |
| Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT00814164 | Leukemia | clofarabine daunorubicin hy... cytogenetic ana... protein express... immunologic tec... pharmacological... | 60 Years - 120 Years | Roswell Park Cancer Institute | |
| S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313 | NCT00896727 | Breast Cancer | gene expression... protein express... fluorescent ant... laboratory biom... | 18 Years - | SWOG Cancer Research Network | |
| Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer | NCT00900523 | Ovarian Cancer | protein express... immunohistochem... | 17 Years - | Vanderbilt-Ingram Cancer Center | |
| Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma | NCT01366170 | Lymphoma | microarray anal... protein express... western blottin... flow cytometry immunohistochem... laboratory biom... mass spectromet... | - 20 Years | Children's Oncology Group | |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases | NCT01234740 | Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult... Tumors Metastat... Adult Anaplasti... | bafetinib microdialysis pharmacological... liquid chromato... mass spectromet... laboratory biom... protein express... western blottin... immunohistochem... therapeutic con... | 18 Years - | City of Hope Medical Center | |
| Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia | NCT00898456 | Leukemia | gene expression... molecular genet... polymorphism an... protein express... diagnostic labo... | 15 Years - | Alliance for Clinical Trials in Oncology | |
| Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases | NCT01234740 | Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult... Tumors Metastat... Adult Anaplasti... | bafetinib microdialysis pharmacological... liquid chromato... mass spectromet... laboratory biom... protein express... western blottin... immunohistochem... therapeutic con... | 18 Years - | City of Hope Medical Center | |
| Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15 | NCT00955435 | Prostate Cancer | Non-interventio... Protein express... Proteomic profi... Laboratory biom... | 18 Years - | Cancer Trials Ireland | |
| Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | NCT00389805 | Lung Cancer Unspecified Adu... | bortezomib pemetrexed diso... gene expression... mutation analys... protein express... reverse transcr... flow cytometry immunoenzyme te... immunohistochem... | 18 Years - 120 Years | University of California, Davis | |
| Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment | NCT00673569 | Lung Cancer | erlotinib hydro... gene expression... protein express... immunoenzyme te... immunologic tec... laboratory biom... needle biopsy | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy | NCT00801385 | Lung Cancer | erlotinib hydro... sorafenib tosyl... DNA analysis mutation analys... polymerase chai... protein analysi... protein express... immunohistochem... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx | NCT00899340 | Head and Neck C... | gene expression... microarray anal... protein express... immunohistochem... laboratory biom... | - | Vanderbilt-Ingram Cancer Center | |
| Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies | NCT00897663 | Brain and Centr... | gene expression... microarray anal... protein express... diagnostic labo... immunohistochem... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors | NCT01196936 | Breast Cancer | Tamoxifen Citra... Placebo Digital mammogr... immunohistochem... pharmacological... laboratory biom... protein express... pharmacogenomic... questionnaire a... Fine needle asp... Quality of Life... | 25 Years - | University of Alabama at Birmingham | |
| Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | NCT01280643 | Metastatic Colo... | fluorouracil leucovorin calc... oxaliplatin irinotecan hydr... bevacizumab cetuximab capecitabine mutation analys... gene expression... laboratory biom... immunohistochem... nucleic acid se... protein express... polymerase chai... DNA analysis | 18 Years - | Fox Chase Cancer Center | |
| Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer | NCT00644384 | Non-melanomatou... | acitretin gene expression... northern blotti... polymerase chai... protein express... laboratory biom... | 18 Years - | Mayo Clinic | |
| Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | NCT00667901 | Melanoma (Skin) | riluzole protein express... reverse transcr... western blottin... immunohistochem... laboratory biom... pharmacological... neoadjuvant the... therapeutic con... | 18 Years - | Rutgers, The State University of New Jersey | |
| CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7 | NCT00812669 | Leukemia | pegfilgrastim rituximab cyclophosphamid... fludarabine pho... cytogenetic ana... fluorescence in... gene expression... mutation analys... protein express... flow cytometry laboratory biom... | 0 Years - 64 Years | Cancer Trials Ireland | |
| AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid Tumors | NCT00372736 | Unspecified Adu... | AEG35156 docetaxel protein express... reverse transcr... flow cytometry immunoenzyme te... immunohistochem... laboratory biom... | 18 Years - | Canadian Cancer Trials Group | |
| Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy | NCT01194635 | Head and Neck C... | fluorescence in... gene expression... polymerase chai... protein analysi... protein express... enzyme-linked i... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer | NCT00436254 | HER2-positive B... Stage III Ovari... Stage III Ovari... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Ovaria... Stage IV Ovaria... | pNGVL3-hICD vac... sargramostim flow cytometry immunologic tec... immunoenzyme te... protein express... biopsy | 18 Years - | University of Washington | |
| Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer | NCT00436254 | HER2-positive B... Stage III Ovari... Stage III Ovari... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Ovaria... Stage IV Ovaria... | pNGVL3-hICD vac... sargramostim flow cytometry immunologic tec... immunoenzyme te... protein express... biopsy | 18 Years - | University of Washington | |
| Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT00814164 | Leukemia | clofarabine daunorubicin hy... cytogenetic ana... protein express... immunologic tec... pharmacological... | 60 Years - 120 Years | Roswell Park Cancer Institute | |
| Sorafenib and Isolated Limb Infusion of Melphalan in Treating Patients With Stage III Melanoma of the Arm or Leg | NCT00565968 | Melanoma (Skin) | melphalan sorafenib tosyl... gene expression... protein express... western blottin... pharmacological... | 18 Years - | Duke University | |
| Aspirin Mouthwash in Treating Patients With Oral Leukoplakia | NCT01238185 | Precancerous Co... | acetylsalicylic... gene expression... protein express... laboratory biom... questionnaire a... biopsy | - | National Cancer Institute (NCI) | |
| Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma | NCT00498927 | Brain and Centr... | temozolomide protein express... reverse transcr... diagnostic labo... immunoenzyme te... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants | NCT00899327 | Leukemia Myelodysplastic... | DNA methylation... RNA analysis cytogenetic ana... gene expression... mutation analys... polymerase chai... protein express... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients | NCT00483457 | Solid Tumor | enzyme inhibito... protein express... immunohistochem... laboratory biom... biopsy | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy | NCT00897299 | Breast Cancer Estrogen Recept... Her-2 Pgr | microarray anal... protein express... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17 | NCT00897065 | Breast Cancer | microarray anal... polymerase chai... protein express... diagnostic labo... fluorescent ant... immunohistochem... immunologic tec... | - | National Cancer Institute (NCI) | |
| Studying Tumor Tissue Samples From Patients With Soft Tissue Sarcoma | NCT00900341 | Sarcoma | DNA analysis gene expression... protein express... reverse transcr... western blottin... immunohistochem... laboratory biom... | - | University of Arizona | |
| Temozolomide in Treating Patients With Invasive Pituitary Tumors | NCT00601289 | Brain and Centr... | temozolomide DNA methylation... microarray anal... protein express... proteomic profi... laboratory biom... | 18 Years - 75 Years | Jonsson Comprehensive Cancer Center | |
| Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery | NCT00665457 | Breast Cancer | filgrastim capecitabine celecoxib cyclophosphamid... docetaxel doxorubicin hyd... gene expression... polymorphism an... protein express... reverse transcr... imaging biomark... immunohistochem... laboratory biom... pharmacogenomic... dynamic contras... needle biopsy neoadjuvant the... radiomammograph... ultrasound imag... | 19 Years - 120 Years | University of Nebraska | |
| Genetic and Epigenetic Determinants of Response to Fluorouracil-based Adjuvant Chemotherapy in Patients With Stage III Colorectal Cancer | NCT03127111 | Stage III Color... | Gene mutations ... Gene methylatio... Gene expression... SNP analysis Protein express... | 18 Years - 70 Years | Renmin Hospital of Wuhan University | |
| Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | NCT00482625 | Intraductal Pap... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | erlotinib hydro... conventional su... immunohistochem... protein express... biopsy pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women) | NCT00499083 | Breast Cancer | therapeutic aut... aromatase inhib... cyclophosphamid... doxorubicin hyd... paclitaxel tamoxifen citra... gene expression... protein express... reverse transcr... immunoenzyme te... immunohistochem... laboratory biom... adjuvant therap... biopsy conventional su... neoadjuvant the... radiation thera... | 19 Years - 120 Years | University of Nebraska | |
| Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | NCT00524589 | Prostate Cancer | calcitriol dexamethasone protein express... laboratory biom... | - 120 Years | Roswell Park Cancer Institute | |
| Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | NCT01280643 | Metastatic Colo... | fluorouracil leucovorin calc... oxaliplatin irinotecan hydr... bevacizumab cetuximab capecitabine mutation analys... gene expression... laboratory biom... immunohistochem... nucleic acid se... protein express... polymerase chai... DNA analysis | 18 Years - | Fox Chase Cancer Center | |
| Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer | NCT00899197 | Breast Cancer | tamoxifen citra... gene expression... protein express... immunoenzyme te... laboratory biom... | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | NCT00514020 | Gastric Cancer | fluorouracil leucovorin calc... oxaliplatin gene expression... polymorphism an... protein express... pharmacological... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer | NCT00674557 | Breast Cancer | SOD1 inhibitor ... exemestane protein express... proteomic profi... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Tumor Tissue Testing in Selecting Treatment for Patients With Metastatic or Locally Advanced Colorectal Cancer | NCT00975897 | Colorectal Canc... | bevacizumab cetuximab fluorouracil irinotecan hydr... leucovorin calc... oxaliplatin RNA analysis cytogenetic ana... fluorescence in... gene expression... mutation analys... protein express... diagnostic labo... immunohistochem... questionnaire a... cognitive asses... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
